Results
20,315 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $248K 1,169 sh | Sep 11, 2026 traded Sep 10, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 1,169 sh | Sep 11, 2026 traded Sep 10, 2026 | |
Taich AdamChief Financial Officer |
 TXG10x Genomics, Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $898K 13.8K sh |
| Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $93K 440 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Briggs TeresaDirector |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $35K 548 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 1,160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $196K 920 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 15 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $525K 468.7K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 15 | Tak Paul PeterDirector, Chief Executive Officer |  CADLCandel Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $621K 59.4K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 14 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $179K 10.2K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Taich AdamChief Financial Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 1,206 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 120 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 80 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $149K 1,630 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 1,100 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 10 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.97M 20.5K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer | OCGNOcugen, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $273K 512 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $344K 640 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $345K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 520 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $277K 522 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $558K 1,040 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Gracey CraigChief Accounting Officer |  OMDAOmada Health, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $837K 1,539 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $87K 160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $652K 1,202 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $184K 347 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $371K 687 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $415K 761 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 362 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 368 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $116K 215 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $212K 396 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $69K 131 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha |  ISRGINTUITIVE SURGICAL INCOpen-market sale · 10b5-1 plan | SELL | $7,996 23 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 3 | Brosius MarkEVP & Chief Mfg and Supply Cha | ISRGINTUITIVE SURGICAL INC Open-market sale · 10b5-1 plan | SELL | $9,145 25 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 1 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $66K 120 sh | Sep 11, 2026 traded Sep 11, 2026 |